Search

everythinglearnresearchcommunity

for

Search:↓

Most hair disorder patients at the clinic were young adult males, with alopecia areata being the most common condition.

Scalp alopecia areata mostly affects young adult males, often starts suddenly, and usually presents as single, patchy lesions.

Sulfasalazine might cause hair loss, especially in women, and stopping it can reverse the hair loss.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

Premature hair graying is common and linked to stress, obesity, vitamin deficiencies, family history, lack of exercise, smoking, and allergies.

Scalp involvement in primary cutaneous lymphomas is common and can be aggressive, requiring careful attention.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

A new type of alopecia areata, called the "confetti variant," causes small bald spots that often heal on their own in a few months.

20% of patients with androgenic alopecia also had metabolic syndrome.

PRP is more effective than triamcinolone for treating alopecia areata.

The study concluded that key signs of Keratosis follicularis spinulosa decalvans are changes in terminal hair and vellus hair follicles, which likely start the inflammation and damage to hair follicles.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Hair disorders include hair loss, excessive hair growth, and ingrown hairs, with various treatments available depending on the cause.

Stress can trigger and worsen vitiligo.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Rash in SLE patients indicates more severe disease.

The document explains how to claim CME credit by diagnosing and treating hair loss conditions in two patient cases.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

CAG repeat numbers in the AR gene likely don't affect male pattern baldness in Korean men.

2.5 mg/day finasteride effectively treats female pattern hair loss.

More severe hair loss and longer treatment improve results.

CAG repeat numbers in the AR gene likely don't affect hair loss in Korean men.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Tryptanthrin effectively suppresses non-melanoma skin cancer and is safe for normal skin.

Quercetin effectively treated and prevented hair loss in mice.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.